The invention relates to use of substituted aromatic polycyclic tertiary-heteroalkylamine compounds as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred substituted aromatic polycyclic tertiary-heteroalkylamine compounds are substituted N-benzyl-N-phenyl aminoalcohols. A preferred specific N-benzyl-N-phenyl aminoalcohol is the compound: ##STR1##

De uitvinding heeft op gebruik van gesubstitueerde aromatische polycyclic tertiair-heteroalkylaminesamenstellingen aangezien betrekking de inhibitors van cholesteryl ester proteïne (CETP; overdracht eiwit-i van het plasmalipide) en samenstellingen, samenstellingen en methodes overbrengen om atherosclerose en andere kransslagaderziekten te behandelen. De aangewezen gesubstitueerde aromatische polycyclic tertiair-heteroalkylaminesamenstellingen zijn gesubstitueerde n-benzyl-n-N-benzyl-N-phenyl aminoalcohols. Aangewezen specifieke n-benzyl-n-N-benzyl-N-phenyl aminoalcohol is de samenstelling: ## STR1 ##

 
Web www.patentalert.com

< Orbital sanding tool

< Countable electronic monetary system and method

> System and method for enhanced online transactions using shopping games

> (R)-Chiral halogenated substituted heteroaryl benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity

~ 00051